A Google Translate screenshot correctly shows that the name of the pharmaceutical company AstraZeneca, when written as “A stra ze neca,” means “a road to death” in Latin. We reached out to ...

Eneboparatide hits primary endpoint in AstraZeneca’s Phase 3 trial for chronic hypoparathyroidism, showing significant efficacy at 24 weeks. The EU approved AstraZeneca’s Imfinzi for limited ...

British drugmaker AstraZeneca has appointed a new China head, replacing a former executive who has been detained by authorities in the country. Iskra Reic, who oversaw the development of the firm ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...

Bloomberg / Contributor / Getty Images A breast cancer drug being developed by AstraZeneca failed to "achieve statistical significance" in helping patients live longer than with chemotherapy in a ...

With healthcare investors crowded into the obesity-focused drugmakers, AstraZeneca, a leader in cancer at a more reasonable valuation, looks like a better bet. If its shareholders are lucky ...

AstraZeneca has appointed WPP as one of its primary oncology network partners. Under WPP’s new remit as a global creative partner, the agency will support U.S. and global advertising for AstraZeneca’s ...

Marcus Brandt / picture alliance via Getty Images AstraZeneca announced plans Tuesday for a “new era of growth" with 75% revenue growth and 20 new drug launches by 2030. The pharmaceutical ...

Where it is also widest, where the river meets the Delaware Bay? Try Narrowsburg, New York. A new map has been published showing the mysterious contours of what is called the “Big Eddy Narrows.” ...

AstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a plethora of new shots that has led to a decline in demand. The vaccine — called Vaxzevria and ...

The pharmaceutical giant AstraZeneca on Tuesday said it is withdrawing its COVID-19 vaccine worldwide citing low demand and a "surplus of available updated vaccines" since the pandemic.

The company’s co-development and recent buyout of Monjuvi is an example. And Incyte isn’t the only one: AstraZeneca, which has had a large presence in Delaware for decades, is expanding into ...